185 related articles for article (PubMed ID: 23722308)
21. A pilot study of clinical efficacy of imiquimod and cryotherapy for the treatment of basal cell carcinoma with incomplete response to imiquimod.
Messeguer F; Serra-Guillen C; Echeverria B; Requena C; Sanmartin O; Llombart B; Guillen C; Nagore E
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):879-81. PubMed ID: 21752102
[TBL] [Abstract][Full Text] [Related]
22. Intralesional cryosurgery for the treatment of basal cell carcinoma of the lower extremities in elderly subjects: a feasibility study.
Har-Shai Y; Sommer A; Gil T; Krausz J; Gal-Or N; Mettanes I; Lavi I; Eyal N; Brizgalin L; Taran A; Har-Shai L; Elmalach I
Int J Dermatol; 2016 Mar; 55(3):342-50. PubMed ID: 26749491
[TBL] [Abstract][Full Text] [Related]
23. An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma.
Wu JK; Oh C; Strutton G; Siller G
Australas J Dermatol; 2006 Feb; 47(1):46-8. PubMed ID: 16405483
[TBL] [Abstract][Full Text] [Related]
24. Treatment of a large superficial basal cell carcinoma with 5% imiquimod: a case report and review of the literature.
Chen TM; Rosen T; Orengo I
Dermatol Surg; 2002 Apr; 28(4):344-6. PubMed ID: 11966794
[TBL] [Abstract][Full Text] [Related]
25. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE
Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
27. Current modalities and new advances in the treatment of basal cell carcinoma.
Ceilley RI; Del Rosso JQ
Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
[TBL] [Abstract][Full Text] [Related]
28. Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas.
Berman B
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s3-6. PubMed ID: 18277456
[TBL] [Abstract][Full Text] [Related]
29. Immunocryosurgery is a safe and feasible treatment for basal cell carcinoma and Bowen disease in renal transplant recipients.
Tsironi T; Gaitanis G; Pappas C; Koutlas V; Dounousi E; Bassukas ID
Dermatol Ther; 2022 May; 35(5):e15405. PubMed ID: 35194902
[TBL] [Abstract][Full Text] [Related]
30. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.
Gollnick H; Barona CG; Frank RG; Ruzicka T; Megahed M; Tebbs V; Owens M; Stampone P
Eur J Dermatol; 2005; 15(5):374-81. PubMed ID: 16172048
[TBL] [Abstract][Full Text] [Related]
31. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
Thissen MR; Kuijpers DI; Krekels GA
J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785
[TBL] [Abstract][Full Text] [Related]
32. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
33. Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
Ruiz ES; Cohen JL; Friedman A
J Drugs Dermatol; 2015 May; 14(5):450-2. PubMed ID: 25942661
[TBL] [Abstract][Full Text] [Related]
34. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
Rigel DS; Torres AM; Ely H
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
[TBL] [Abstract][Full Text] [Related]
35. Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod.
MacFarlane DF; El Tal AK
Arch Dermatol; 2011 Nov; 147(11):1326-7. PubMed ID: 22106125
[No Abstract] [Full Text] [Related]
36. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
37. Basal cell carcinoma: treatment with imiquimod.
Bukhardt Pérez MP; Ruiz-Villaverde R; Naranjo Díaz MJ; Blasco Melguizo J; Naranjo Sintes R
Int J Dermatol; 2007 May; 46(5):539-42. PubMed ID: 17472691
[TBL] [Abstract][Full Text] [Related]
38. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
[TBL] [Abstract][Full Text] [Related]
40. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
Spencer JM
Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]